Bio-Path Balance Sheet - Quarterly (NASDAQ:BPTH)

Add to My Stocks
$1.01 $0.07 (6.48%) BPTH stock closing price Sep 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Bio-Path balance sheet. Financial strength can be guaged by performing Bio-Path stock analysis and by analyzing the balance sheet. Quarterly results are typically accompanied with the company releasing financial statements. The balance sheet shows total liabilities of $1.01M and shareholders equity of $4.74M. Bio-Path revenue and Bio-Path operating cash flow are important in understanding the financial capacity of the company.

View and download Bio-Path quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash2.58M4.28M5.96M4.62M6.18M7.11M9.37M11.29M4.22M6.47M
Marketable Securities----------
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.94M1.58M1.47M1.16M1.6M1.23M1.27M1.1M1.85M1.36M
Total Current Assets
4.51M5.87M7.43M5.78M7.78M8.35M10.65M12.4M6.07M7.83M
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles--------1.01M1.05M
Deposits & Other Assets----------
Total Assets
5.74M7.2M8.85M7.31M9.43M10.11M12.19M13.44M7.14M8.94M
Notes Payable----------
Accounts Payable----------
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
1.01M-----1.05M---
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities-----1.31M2.9M3.19M--
Total Liabilities
1.01M----2.01M3.95M4.06M--
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus47.48M47.33M47.21M43.43M43.27M40.52M40.27M40.04M35.43M35.2M
Retained Earnings-42.75M-41.07M-39.15M-36.99M-34.51M-32.53M-32.13M-30.76M-29.19M-27.25M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity4.74M6.27M8.06M6.54M8.85M8.09M8.24M9.37M6.32M8.04M
Total Liabilities & Shareholders Equity5.74M7.2M8.85M7.31M9.43M10.11M12.19M13.44M7.14M8.94M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Bio-Path stock price by looking at Bio-Path historical stock prices. One can compare PE with industry average by looking at the Bio-Path PE ratio chart. The common balance sheet items are:

  • Assets: BPTH total assets, which was at $5.74M for 2018 Q2 is a balance sheet item representing value of what Bio-Path owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Bio-Path's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for BPTH stock stand at $1.01M.

Bio-Path Balance Sheet - Key Ratios